CDSCO increases licence fee for various application procedures

Published On 2018-12-23 04:35 GMT   |   Update On 2018-12-23 04:35 GMT

New Delhi: Through a recent office memorandum, the Central Drugs Standard Control Organization(CDSCO) announced the Implementation of increase in application fees for grant of various import licences, registration certificates for Drugs and Cosmetics and permission for import of New Drugs and Fixed-Dose Combinations under the provisions of Drugs & Cosmetics Rules, 1945


The notice states that for the same, the Drugs and Cosmetics Rules, 1945 have been amended vide G.S.R.1193(E) dated 12.12.2018 with immediate effect to increase the application fees for grant of various import licences, registration certificates for Drugs and Cosmetics and permission for import of New Drugs and Fixed-Dose Combinations under the Rules.


"Any application for grant of such import licences, registration certificates for Drugs and Cosmetics and permission for import of New Drugs and Fixed-Dose Combinations as covered under the said amendment received on or after 12.12.2018 shall be accompanied by the increased fees in accordance with the amendment," the notice added


Concerned officers in CDSCO (HQ) and its Zonal, Sub-zonal and Port offices haave been directed to ensure implementation of the above amendment in the Drugs and Cosmetics Rules, 1945 with effect from 12.12.2018.


Attached below is the notification.


Also Read: CDSCO issues PUBLIC NOTICE asking for feedback on online portal SUGAM

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News